세계의 임플란트 주위염 치료 시장 예측 : 치료 유형별, 원인 유형별, 임플란트 유형별, 디바이스 유형별, 최종 사용자별, 지역별 분석(-2030년)

According to Stratistics MRC, the Global Peri-Implantitis Treatment Market is accounted for $1.1 billion in 2024 and is expected to reach $2.1 billion by 2030 growing at a CAGR of 10.7% during the forecast period. Peri-implantitis treatment involves managing inflammation and infection around a dental implant, typically affecting the tissues surrounding the implant. Treatment options vary depending on the severity of the condition but often include non-surgical methods like mechanical debridement (cleaning) and antiseptic rinses to reduce bacterial load. In more severe cases, surgical interventions such as flap surgery may be necessary to access and clean deeper areas. Antibiotics and proper oral hygiene are essential for preventing recurrence and ensuring long-term implant success.

According to NCBI, the prevalence of peri-implantitis was 34.0% on the patient level and 21% on the implant level over an average follow-up of 2 years in the U.S.

Market Dynamics:

Driver:

Increasing usage of dental implants

The increasing use of dental implants has significantly boosted the market. As more people opt for dental implants for tooth replacement, the demand for effective treatments for peri-implantitis, a common complication, rises. This has led to advancements in diagnostic techniques and therapeutic options, including non-surgical interventions and minimally invasive procedures, driving growth in the market. The focus on long-term implant success further enhances the demand for specialized peri-implantitis treatments.

Restraint:

Shortage of skilled specialists

The shortage of skilled specialists in the market negatively impacts patient outcomes and the overall effectiveness of treatments. With limited expertise, the diagnosis and management of peri-implantitis may be delayed or inadequate, leading to higher failure rates of implants and prolonged recovery times. This shortage also hampers innovation, restricts access to advanced care, and increases the burden on existing specialists, resulting in longer waiting times and reduced treatment availability.

Opportunity:

Public awareness of oral hygiene

Rising public awareness of oral hygiene has positively impacted the market. As more individuals recognize the importance of maintaining oral health, especially around dental implants, there is an increased focus on preventing peri-implantitis. Educational campaigns on proper care, hygiene practices, and early detection contribute to better prevention and management of the condition. This growing awareness drives demand for effective treatment options and promotes long-term implant success.

Threat:

High treatment costs

High treatment costs in the market pose a significant barrier to access for many patients. The advanced procedures, including surgical interventions and specialized care, often require expensive equipment and expertise, driving up costs. This financial burden can limit patient access to necessary treatments, potentially leading to worsened conditions or implant failure. As a result, individuals may delay or forgo treatment, exacerbating long-term health complications and increasing overall healthcare costs.

Covid-19 Impact:

The COVID-19 pandemic significantly disrupted the peri-implantitis treatment market by causing delays in elective dental procedures, including implant-related treatments. Lockdowns and social distancing measures led to reduced patient visits, staff shortages, and a focus on urgent care, slowing down the diagnosis and management of peri-implantitis. Additionally, financial uncertainties and restrictions on non-essential services led to increased costs and limited access to specialized care, affecting overall treatment outcomes.

The titanium implants segment is expected to be the largest during the forecast period

The titanium implants segment is expected to account for the largest market share during the projection period due to the increasing prevalence of dental implant procedures. Titanium's biocompatibility and resistance to corrosion make it a preferred material for implants. Advancements in implant design, surface modifications, and therapeutic approaches are driving market expansion, with a focus on improving long-term implant success rates and reducing complications such as infection and bone loss.

The dental clinics segment is expected to have the highest CAGR during the forecast period

The dental clinics segment is expected to have the highest CAGR during the extrapolated period. Dental clinics are increasingly adopting advanced diagnostic tools and treatment techniques, including laser therapy, antimicrobial agents, and regenerative procedures, to manage peri-implantitis. The growing awareness of implant failure risks and the need for effective interventions are driving demand for specialized treatments in these settings, fostering market growth.

Region with largest share:

North America region is estimated to account for the largest market share during the forecast period due to the rising number of dental implants. Advances in diagnostic and therapeutic technologies, including laser treatments and regenerative techniques, are driving the market. The region's well-established healthcare infrastructure, along with a high demand for dental care services, supports the market's expansion, positioning the region as a key hub for peri-implantitis treatment innovations.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period driven by increasing oral health issues, rising awareness, and supportive healthcare policies. The prevalence of dental caries and periodontal disease is alarmingly high in the region, particularly among older adults. There is a growing awareness regarding oral health, which is crucial for driving demand for peri-implantitis treatments. Moreover, Favorable government policies and advancements in healthcare infrastructure are also contributing to market expansion.

Key players in the market

Some of the key players in Peri-Implantitis Treatment market include Pfizer Inc., Cadila Pharmaceuticals, R N. Laboratories, Triveni Chemicals, Arthrex, Zimmer Biomet Dental, Stryker, Smith & Nephew, Danaher, 3M, Meyer Dental Laboratory, Cochlear Limited, Medtronic, Bicon Dental Implants, Cendres+Metaux, Straumann AG and Fotona.

Key Developments:

In July 2024, Fotona announced the opening of the Laser & Health (LA&HA) Academy Training Center in Malaysia. Designed to support all Fotona users and practitioners, the new center aims to enhance knowledge, foster collaboration, and achieve clinical excellence.

In February 2024, Straumann has announced the complete acquisition of GalvoSurge, a Swiss medical device company specializing in dental implant care and maintenance solutions. GalvoSurge has developed an innovative approach to support peri-implantitis treatment, with its CE-marked device launched in 2020.

Treatment Types Covered:

• Non-Surgical Treatments
• Surgical Treatments
• Combination Treatments
• Other Treatment Types

Cause Types Covered:

• Bacterial Infection
• Excessive Occlusal Loading
• Implant Design or Placement Issues
• Biological

Implant Types Covered:

• Titanium Implants
• Zirconia Implants
• Ceramic Implants
• Hydroxyapatite Coatings
• Polymer-Based Implants

Device Types Covered:

• Ultrasonic Devices
• Lasers
• Bone Grafting Materials
• Surgical Instruments

End Users Covered:

• Dental Clinics
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Peri-Implantitis Treatment Market, By Treatment Type

• 5.1 Introduction
• 5.2 Non-Surgical Treatments
  • 5.2.1 Mechanical Debridement
  • 5.2.2 Laser Therapy
  • 5.2.3 Antimicrobial Therapy
  • 5.2.4 Local Drug Delivery
• 5.3 Surgical Treatments
  • 5.3.1 Flap Surgery
  • 5.3.2 Bone Grafting
  • 5.3.3 Guided Bone Regeneration (GBR)
• 5.4 Combination Treatments
• 5.5 Other Treatment Types

6 Global Peri-Implantitis Treatment Market, By Cause Type

• 6.1 Introduction
• 6.2 Bacterial Infection
• 6.3 Excessive Occlusal Loading
• 6.4 Implant Design or Placement Issues
• 6.5 Biological

7 Global Peri-Implantitis Treatment Market, By Implant Type

• 7.1 Introduction
• 7.2 Titanium Implants
• 7.3 Zirconia Implants
• 7.4 Ceramic Implants
• 7.5 Hydroxyapatite Coatings
• 7.6 Polymer-Based Implants

8 Global Peri-Implantitis Treatment Market, By Device Type

• 8.1 Introduction
• 8.2 Ultrasonic Devices
• 8.3 Lasers
• 8.4 Bone Grafting Materials
• 8.5 Surgical Instruments

9 Global Peri-Implantitis Treatment Market, By End User

• 9.1 Introduction
• 9.2 Dental Clinics
• 9.3 Hospitals
• 9.4 Ambulatory Surgical Centers (ASCs)
• 9.5 Other End Users

10 Global Peri-Implantitis Treatment Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Pfizer Inc.
• 12.2 Cadila Pharmaceuticals
• 12.3 R N. Laboratories
• 12.4 Triveni Chemicals
• 12.5 Arthrex
• 12.6 Zimmer Biomet Dental
• 12.7 Stryker
• 12.8 Smith & Nephew
• 12.9 Danaher
• 12.10 3M
• 12.11 Meyer Dental Laboratory
• 12.12 Cochlear Limited
• 12.13 Medtronic
• 12.14 Bicon Dental Implants
• 12.15 Cendres+Metaux
• 12.16 Straumann AG
• 12.17 Fotona